3.3. The challenge in using NPM reports in cross-border proceedings.....................................88
3.4. Ways for NPMs to provide specific information in cross-border cases...............................93
3.5. Monitoring assurances:
Beyond NPMs‘ mandate, yet relevant to the prevention of ill-treatment..........................94
3.6. Promoting the prevention of ill-treatment in EU legislation...............................................96
3.7. How enhanced engagement between judiciary and NPMs contributes to the
prevention of ill-treatment: Conclusions and recommendations ......................................97
Conclusions.........................................................................................................................97
Recommendations .............................................................................................................99
Chapter 4.
The Role of international bodies .............................................................................................. 101
4.1. The Subcommittee on Prevention of Torture (SPT)..........................................................101
4.2. The European Committee for the Prevention of Torture (CPT).........................................102
4.3. EU Agency for Fundamental Rights . ................................................................................103
4.4. Eurojust.............................................................................................................................104
4.5. The European Commission ..............................................................................................105
Concluding Thoughts .......................................................................................................108
Bibliography .....................................................................................................................110
4